Literature DB >> 1377976

MR imaging characteristics of noncancerous lesions of the prostate.

K Lovett1, M D Rifkin, P A McCue, H Choi.   

Abstract

Radical prostatectomy specimens from 53 men with clinical stage A or B prostate cancer were retrospectively reviewed and compared with correlative axial T2-weighted magnetic resonance (MR) images obtained just before surgery. Non-cancerous lesions were evaluated for signal intensity and location. Focal high-signal-intensity areas (n = 72) were present in 81% of patients. The 26% of lesions seen in the central gland all correlated with cystic atrophy. Of the 53 lesions seen in the peripheral prostate, 47 (89%) were cystic atrophy without associated cancer, four (7.5%) cystic atrophy with cancer, and two (3.8%) focal inflammation. Focal low-signal-intensity areas (n = 42) were present in 60% of patients. Of the 31% of lesions in the central prostate, one-fifth correlated with benign prostatic hyperplasia (BPH) and four-fifths with fibrous tissue. Of the 69% of peripheral lesions, 83% corresponded to fibrous tissue, 10% to BPH, and 7% to normal tissue. Mixed lesions (n = 42) were present in 64% of patients; 86% of these were located centrally and 14% peripherally. All mixed central lesions were BPH; the peripheral lesions were areas of combined cystic atrophy and fibrosis. BPH of low or mixed signal intensity can extend into the peripheral prostate and mimic cancer. High-intensity cystic atrophy associated with cancer can mimic normal tissue.

Entities:  

Mesh:

Year:  1992        PMID: 1377976     DOI: 10.1002/jmri.1880020106

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  8 in total

1.  Reproducibility of image interpretation in MRI of the prostate: application of the sextant framework by two different radiologists.

Authors:  Ullrich Mueller-Lisse; Ulrike Mueller-Lisse; Juergen Scheidler; Gerhardt Klein; Maximilian Reiser
Journal:  Eur Radiol       Date:  2005-04-20       Impact factor: 5.315

2.  Multiparametric MRI Features and Pathologic Outcome of Wedge-Shaped Lesions in the Peripheral Zone on T2-Weighted Images of the Prostate.

Authors:  Aritrick Chatterjee; Sevil Tokdemir; Alexander J Gallan; Ambereen Yousuf; Tatjana Antic; Gregory S Karczmar; Aytekin Oto
Journal:  AJR Am J Roentgenol       Date:  2018-11-07       Impact factor: 3.959

Review 3.  Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer.

Authors:  Antonio C Westphalen; David A McKenna; John Kurhanewicz; Fergus V Coakley
Journal:  J Endourol       Date:  2008-04       Impact factor: 2.942

4.  Determination of the cutoff level of apparent diffusion coefficient values for detection of prostate cancer.

Authors:  Masako Nagayama; Yuji Watanabe; Akito Terai; Tohru Araki; Kenji Notohara; Akira Okumura; Yoshiki Amoh; Takayoshi Ishimori; Satoru Nakashita; Yoshihiro Dodo
Journal:  Jpn J Radiol       Date:  2011-09-01       Impact factor: 2.374

5.  Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate.

Authors:  Pieter J L De Visschere; Anne Vral; Gianpaolo Perletti; Eva Pattyn; Marleen Praet; Vittorio Magri; Geert M Villeirs
Journal:  Eur Radiol       Date:  2016-08-04       Impact factor: 5.315

6.  Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer.

Authors:  Rajakumar Nagarajan; Daniel Margolis; Steven Raman; Ke Sheng; Christopher King; Robert Reiter; M Albert Thomas
Journal:  Adv Urol       Date:  2011-12-15

Review 7.  MR Imaging-Histology Correlation by Tailored 3D-Printed Slicer in Oncological Assessment.

Authors:  D Baldi; M Aiello; A Duggento; M Salvatore; C Cavaliere
Journal:  Contrast Media Mol Imaging       Date:  2019-05-29       Impact factor: 3.161

8.  Prostate cancer: added value of subtraction dynamic imaging in 3T magnetic resonance imaging with a phased-array body coil.

Authors:  Jeong-Sik Yu; Jae-Joon Chung; Soon Won Hong; Byung Ha Chung; Joo Hee Kim; Ki Whang Kim
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.